| Product NDC: | 0168-0216 |
| Proprietary Name: | Erythromycin |
| Non Proprietary Name: | erythromycin |
| Active Ingredient(s): | 20 mg/g & nbsp; erythromycin |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | GEL |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0168-0216 |
| Labeler Name: | E. FOUGERA & CO., A division of Fougera Pharmaceuticals Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA064184 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19970930 |
| Package NDC: | 0168-0216-60 |
| Package Description: | 60 g in 1 TUBE (0168-0216-60) |
| NDC Code | 0168-0216-60 |
| Proprietary Name | Erythromycin |
| Package Description | 60 g in 1 TUBE (0168-0216-60) |
| Product NDC | 0168-0216 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | erythromycin |
| Dosage Form Name | GEL |
| Route Name | TOPICAL |
| Start Marketing Date | 19970930 |
| Marketing Category Name | ANDA |
| Labeler Name | E. FOUGERA & CO., A division of Fougera Pharmaceuticals Inc. |
| Substance Name | ERYTHROMYCIN |
| Strength Number | 20 |
| Strength Unit | mg/g |
| Pharmaceutical Classes | Decreased Sebaceous Gland Activity [PE],Macrolide [EPC],Macrolide Antimicrobial [EPC],Macrolides [Chemical/Ingredient] |